BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2024 3:55:02 PM | Browse: 299 | Download: 1177
 |
Received |
|
2024-03-09 11:26 |
|
Peer-Review Started |
|
2024-03-09 11:26 |
|
First Decision by Editorial Office Director |
|
2024-04-16 21:09 |
|
Return for Revision |
|
2024-04-16 21:09 |
|
Revised |
|
2024-04-23 15:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-29 03:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-29 09:02 |
|
Articles in Press |
|
2024-04-29 09:02 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-27 15:44 |
|
Publish the Manuscript Online |
|
2024-06-04 15:55 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Renin-angiotensin system inhibitor prescriptions in Chinese hospitalized chronic kidney disease patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chun Zhang, Zhi-Yu Duan, Sa-Sa Nie, Zhou Zhang, Xin-Ru Guo, Chao-Yang Zhang, Jing Dong and Guang-Yan Cai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guang-Yan Cai, PhD, Chief Physician, Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing 100853, China. vinxiong66@163.com |
| Key Words |
Chronic kidney disease; Renin-angiotensin system inhibitors; Prescriptions; Adherence |
| Core Tip |
This study examines the prescribing trends of renin-angiotensin system inhibitors (RASI) in hospitalized Chinese chronic kidney disease (CKD) patients from 2010 to 2019. Despite guidelines recommending RASI as first-line therapy, findings reveal a peak in prescriptions around 2015-2016, followed by a slight decline. Factors such as younger age, male gender, and non-acute conditions increased RASI prescription likelihood. The research highlights a need for improved adherence to clinical guidelines in RASI application to enhance CKD patient care outcomes. |
| Publish Date |
2024-06-04 15:55 |
| Citation |
Zhang C, Duan ZY, Nie SS, Zhang Z, Guo XR, Zhang CY, Dong J, Cai GY. Renin-angiotensin system inhibitor prescriptions in Chinese hospitalized chronic kidney disease patients. World J Clin Cases 2024; 12(17): 3061-3075
|
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i17/3061.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i17.3061 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
